Romney’s Prognosis Good after Prostate Cancer Surgery, Says Renowned Urologic Oncologist Dr. David Samadi

Former Republican presidential candidate Mitt Romney recently announced that a successful prostate surgery was performed on him last summer to treat a slow-growing tumor. Many see the disclosure of this medical procedure as a sign that Romney is going to run for the soon-to-be-vacated Utah Senate seat. The surgery in question was done by Dr. Thomas Ahlering at UC Irvine Hospital in California, and Romney’s prognosis for the future is said to be good.

According to Dr. David Samadi, an expert in the field of prostate surgery, Romney is one of 161,361 men who were diagnosed with some form of prostate cancer in 2017. Prostate cancer almost always appears in older men; about 60 percent of those diagnosed are at least 65, and it’s almost unheard of for prostate cancer to appear in men aged 40 or younger. Mr. Romney was 70 years old at the time of the surgery.

Dr. Samadi reports that in cases of prostate cancer, men must usually decide if they wants the tumor to be treated with surgery or radiation. Dr. Samadi usually suggests surgery to his patients for a variety of reasons. Men whose cancer is contained to the prostate gland have better results from surgery than radiation according to multiple studies, and men who undergo radiation therapy are twice as likely to die from prostate cancer. It is also more difficult for surgery to be performed after radiation has already been used if the cancer does come back. However, Dr. Samadi suggests that men with prostate cancer should ask their surgeon about their experience in treating prostate cancer, and how many surgeries they’ve performed, before making a decision.

About Dr. Samadi

Dr. David Samadi is a certified urologic oncologist and one of the world’s most accomplished prostate surgeons, having successfully treated hundreds of patients. He is also an expert in robotic surgery; using the da Vinci robotic surgery system, he has performed over 7000 robotic prostate surgeries.

David Samadi received his fellowship training at the world-renowned Memorial Sloan-Kettering Cancer Center, where he learned to treat prostate cancer as well as bladder and testicular cancer. He currently serves as the Chairman of Urology as well as the Chief of Robotic Surgery at New York’s Lenox Hill Hospital. Previously, Dr. Samadi was the Vice-Chair of Urology at the Mount Sinai Medical Center, and he has also served as a health and medical consultant for Fox News since 2009.

To know more visit @